Position in GERN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$5,741,509
-$1,321,162 QoQ
Shares Held
4,485,554
-5.4% QoQ
Ownership
0.698%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#23
of 258 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 55%
Shared 0%
None 45%
Common Shares in GERN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SEGALL BRYANT & HAMILL, LLC holds $322,746,195 across 29 Biotechnology names. GERN ranks #19 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTGX |
Protagonist Therapeutics, Inc
|
214,724 | $26,320,867 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
317,924 | $24,883,911 | |
| 3 | KRYS |
Krystal Biotech, Inc.
|
65,211 | $24,236,972 | |
| 4 | PTCT |
Ptc Therapeutics, Inc.
|
271,735 | $22,165,423 | |
| 5 | TECH |
BIO-TECHNE Corp
|
312,035 | $22,045,272 | |
| 6 | CYTK |
Cytokinetics Inc
|
257,063 | $21,899,196 | |
| 7 | MIRM |
Mirum Pharmaceuticals, Inc.
|
178,980 | $20,953,188 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
37,072 | $18,414,774 |
All Filings in GERN
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,741,509 | 4,485,554 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $7,062,671 | 4,740,048 | Shares | Sole | 2026-05-22 | |
| 2025-12-31 | $6,664,595 | 5,048,936 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,309,245 | 5,335,216 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $10,140,979 | 7,192,184 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $11,808,697 | 7,426,854 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $26,359,813 | 7,446,275 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $18,509,938 | 4,077,079 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $17,457,504 | 4,117,336 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $14,681,356 | 4,448,896 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $9,325,820 | 4,419,820 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $10,579,857 | 4,990,499 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $11,057,769 | 3,444,788 | Shares | Sole | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||